Evidence map›Paper›PMID 41332559›Full record

ArticlebioRxiv : the preprint server for biology2025

Rab11B is required for binding and entry of recent H3N2, but not H1N1, influenza A isolates.

Allyson H Turner, Sara A Jaffrani, Hannah C Kubinski, Deborah P Ajayi, Matthew B Owens, Conor D Fanuele, Madeline P McTigue, Cailey L Appenzeller, Addington Bowling, Hannah W Despres and 5 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Allyson H TurnerDepartment of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, USA.ORCID 0009-0009-9576-6095
Sara A JaffraniDepartment of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, USA.
Hannah C KubinskiDepartment of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, USA.
Deborah P AjayiDepartment of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, USA.
Matthew B OwensDepartment of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, USA.
Conor D FanueleDepartment of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, USA.
Madeline P McTigueDepartment of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, USA.
Cailey L AppenzellerDepartment of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, USA.
Addington BowlingDepartment of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, USA.
Hannah W DespresDepartment of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, USA.
Madaline M SchmidtDepartment of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, USA.
Dave J ShirleyFaraday, Inc. Data Science Department, Burlington, Vermont, United States of America.
Jessica W CrothersDepartment of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT, USA.
Ramiro Barrantes-ReynoldsDepartment of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, USA.
Emily A BruceDepartment of Microbiology and Molecular Genetics, University of Vermont, Burlington, Vermont, USA.ORCID 0000-0001-8391-370X

Funding

Using Dengue Controlled Human Infection Model to Identify Adaptive Immune Correlates of ProtectionP20GM125498 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI Beth Diane Kirkpatrick · 2018 to 2026
$24.9M
Understanding the Development of Mucosal Immunity to Poliovirus: Adjuvants and Modulation of the Enteric MicrobiotaK23AI175660 · NIAID · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI Jessica W. Crothers · 2024 to 2026
$485k
NIAID NIH HHS K23 AI175660NIGMS NIH HHS P20 GM125498
6 · The paper itself

Abstract

As an obligate intracellular parasite, influenza A virus (IAV) depends on host proteins to complete several important functions, including trafficking viral proteins throughout the cell. Previous work has established a critical role for the cellular vesicular trafficking protein, Rab11A, in transporting the viral genome segments to the site of budding at the plasma membrane. While the role of Rab11A in IAV assembly is relatively well understood, very little is known about the function of a closely related isoform (Rab11B) during influenza virus infection. We have shown that both Rab11A and Rab11B are required for successful IAV infection by current H1N1 or H3N2 isolates. Cells in which either Rab11A or Rab11B were depleted failed to efficiently produce virus, with significant reductions in infectious titer. Surprisingly, our data revealed that recent (2022) H3N2, but not H1N1, isolates failed to efficiently produce viral proteins in single-cycle infections when Rab11B (but not Rab11A) was depleted. Flow cytometry analysis suggests that the defect in protein production is driven by a reduction in the total number of infected cells, rather than a decrease in viral protein production at the single cell level. Using reverse genetics and '7+1' reassortant viruses we mapped this Rab11B-dependent early defect in recent H3N2 isolates to the HA gene. RT-qPCR analysis of H3N2 virions bound to the cell surface showed a ~50% decrease in virus binding the surface of cells depleted of Rab11B, but not Rab11A. This data suggests a novel role for Rab11B during viral entry, likely at the stage of viral binding, that is specific to H3N2 isolates.

Identifiers

PMID41332559
PMCPMC12667821

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.